Summary
77 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 20 EUR is left as net profit.
- Earnings per share grew by 28% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for 1.34B € in the last fiscal year, 5.3% of its market value.
What to watch
- Revenue growth is slowing: 13% a year over the last 3 years against 25% over 5 years.
- For every 100 EUR of bills due within a year it has 74 EUR of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.4 EUR for 1 EUR of yearly profit. Over the last five years it was 26.6 EUR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 25% a year over 5 years. Over the last 3 years it grew by 13% a year. For the next fiscal year analysts expect revenue to grow by 4.7%. Earnings per share grew by 28% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 59 EUR
- Research and development 5.3 EUR
- Sales and administration 9.0 EUR
- Taxes and other 7.1 EUR
- Net profit 20 EUR
Net profit, industry median (Information Technology Services) 6.0 EUR
Out of every 100 EUR of revenue, 20 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 2.55%
- Paid out of profit
- 49%
- Raised in a row
- 1 year
You receive 1.54 € per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail